CJ Bioscience, Inc. (KOSDAQ: 311690)

CJ Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	49,754	64,095	49,324	62,060	13,255	5,354
Short-Term Investments	-	-	-	18,020	-	-
Trading Asset Securities	-	-	-	-	26,020	25,732
Cash & Short-Term Investments	49,754	64,095	49,324	80,080	39,275	31,086
Cash Growth	131.98%	29.95%	-38.41%	103.89%	26.35%	188.69%
Accounts Receivable	123.94	160.91	303.82	233.62	99.46	96.3
Other Receivables	473.94	178.66	523.06	474.16	257.47	97.79
Receivables	597.87	339.57	826.88	707.78	356.93	194.09
Inventory	232.2	157.82	76.16	145.83	364.31	98.67
Prepaid Expenses	861.55	355.71	446.57	259.18	499.9	126.59
Other Current Assets	231.85	262.22	258.72	362.03	592.63	136.89
Total Current Assets	51,677	65,210	50,932	81,555	41,089	31,642
Property, Plant & Equipment	10,830	12,707	14,364	9,856	19,991	1,728
Long-Term Investments	2	2	2	0	-	0
Other Intangible Assets	12,439	12,397	1,016	114.13	103.95	126.11
Other Long-Term Assets	831.22	811.16	25,075	24,830	12,178	244.86
Total Assets	75,779	91,128	91,389	116,355	73,362	33,741
Accounts Payable	168.84	122.82	336.65	287.75	708.93	288.86
Accrued Expenses	3,174	3,966	3,996	140.94	169.76	137.66
Short-Term Debt	5,112	3,971	23,588	18,441	-	-
Current Portion of Leases	1,848	1,869	1,547	1,361	205.9	370.01
Other Current Liabilities	4,324	4,793	5,511	3,606	1,919	1,508
Total Current Liabilities	14,627	14,722	34,979	23,836	3,004	2,305
Long-Term Debt	-	-	-	-	35,081	-
Long-Term Leases	1,944	2,692	3,831	4,088	479.37	368.16
Other Long-Term Liabilities	2,818	2,152	2,924	577.4	314.4	213.6
Total Liabilities	19,674	19,633	41,734	28,502	38,878	2,887
Common Stock	4,556	4,556	2,939	2,937	1,946	1,904
Additional Paid-In Capital	151,426	151,426	108,066	112,186	40,993	31,780
Retained Earnings	-101,077	-85,951	-62,738	-28,035	-8,763	-4,222
Comprehensive Income & Other	1,200	1,465	1,389	765.25	307.61	1,393
Shareholders' Equity	56,105	71,496	49,655	87,853	34,484	30,855
Total Liabilities & Equity	75,779	91,128	91,389	116,355	73,362	33,741
Total Debt	8,905	8,533	28,966	23,891	35,766	738.17
Net Cash (Debt)	40,849	55,562	20,357	56,190	3,509	30,348
Net Cash Growth	-	172.93%	-63.77%	1501.15%	-88.44%	181.83%
Net Cash Per Share	4695.25	7843.75	3463.50	13214.21	908.96	9191.08
Filing Date Shares Outstanding	9.11	9.11	5.88	5.87	3.89	3.81
Total Common Shares Outstanding	9.11	9.11	5.88	5.87	3.89	3.81
Working Capital	37,050	50,488	15,953	57,718	38,085	29,337
Book Value Per Share	6156.95	7845.89	8446.71	14957.10	8859.45	8100.57
Tangible Book Value	43,666	59,098	48,640	87,739	34,380	30,729
Tangible Book Value Per Share	4791.88	6485.40	8273.89	14937.67	8832.74	8067.46
Land	-	-	-	-	13,973	-
Buildings	-	-	-	-	2,563	-
Machinery	-	13,686	10,339	4,411	3,488	3,206
Construction In Progress	-	-	521.7	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.